CONMED Corporation
CNMDNYSEHealthcareMedical Devices
As of Oct 22, 2026 close
- Market cap
- $1.49B
- P/E (TTM)
- 26.36
- Forward P/E
- 52.41
- Dividend yield
- -
- 52-week range
- $31.44$53.66
- Volume (live)
- -
- Avg. volume (3M)
- 385.39K
CONMED (CNMD) Stock Price & Financial Analysis
CONMED Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $47.38 - $49.56 |
|---|---|
| 52-Week High | $53.66 |
| 52-Week Low | $31.44 |
| Open | $47.38 |
| Volume (last close) | 398.58K |
| Average Volume (3M) | 385.39K |
| Revenue (TTM) | 1.37B |
|---|---|
| Net Income (TTM) | 56.50M |
| Free Cash Flow (TTM) | 134.46M |
| EPS (TTM) | $1.84 |
| Profit Margin | 4.12% |
| Operating Margin | 8.04% |
| Return on Equity (ROE) | 5.43% |
| Debt to Equity | 0.80 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Last Dividend Ex-Date | Sep 15, 2025 |
| Market Cap | 1.49B |
|---|---|
| Shares Outstanding | 30.12M |
| P/E Ratio (TTM) | 26.36 |
| Forward P/E | 52.41 |
| Price to Sales (P/S) | 1.09 |
| Price to Book (P/B) | 1.43 |
| EV/EBITDA | 10.72 |
| 50-Day MA | $47.56 |
|---|---|
| 200-Day MA | $41.23 |
| 1-Year Change | +2.45% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
CONMED at a Glance
As of the Oct 22, 2026 close, CONMED (CNMD) has a market capitalization of $1.49B. The stock trades at 26.4× trailing earnings, 52.4× forward earnings and 1.1× sales. Over the trailing twelve months it earned $56.50M on revenue of $1.37B (a 4.1% profit margin) and generated $134.46M of free cash flow. Revenue grew 3.6% year over year.
As of its latest reported balance sheet, it holds $37.33M in cash and securities against $834.25M of debt, a net debt position of $796.92M.
CONMED does not currently pay a dividend.
The share price is up 2.4% over the past year. At $49.44 (the Oct 22, 2026 close) it sits within its 52-week range of $31.44 to $53.66, above its 200-day moving average of $41.23.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $45.25, 8.5% below the Oct 22, 2026 close.
Frequently Asked Questions About CONMED
What is the current stock price for CNMD?
As of the Oct 22, 2026 close, CNMD stock trades at $49.44. The 52-week range is $31.44–$53.66, with a day range of $47.38–$49.56.
What is the P/E ratio for CNMD?
As of the Oct 22, 2026 close, CONMED's trailing twelve-month (TTM) P/E ratio is 26.4, meaning investors pay $26.4 for every $1 of annual earnings. The forward P/E is 52.4, reflecting analyst expectations for future earnings. CONMED operates in the Healthcare sector.
Does CNMD pay dividends?
CONMED does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for CNMD?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for CNMD is Hold. The average 12-month price target is $45.25, a 8.5% downside from the Oct 22, 2026 close of $49.44.
What is the market cap of CNMD?
As of the Oct 22, 2026 close, CONMED's market capitalization is $1.49B, classifying it as a small-cap company. CONMED operates in the Healthcare sector within the Medical Devices industry.